Turenne Capital is a private equity management and venture capital company.
Business Model:
Revenue: $20M
Employees: 51-200
Address: 9 rue Tehran
City: Paris
State: other
Zip: 75008
Country: FR
Turenne Capital is an independant private equity management company, with 4 offices in France : - Paris - Lyon - Marseilles - Lille (joint-venture). Since 1999, Turenne Capital has been taking significant minority or majority equity stakes alongside entrepreneurs who operate SMEs with revenues ranging from €5 million to € 100 million. It invests between €1 million and €10 million per transaction. Turenne Capital manages/advises more than € 500 million. 32 people, among which 21 investors work in the Group. ------------------------------------------------------------------------------ Turenne Capital est une Société de gestion indépendante spécialisée en capital investissement. Turenne Capital accompagne depuis 1999 des entrepreneurs dans leur développement et la transmission de leur société et est implantée à : - Paris - Lyon - Marseille - Lille (filiale) Les tickets d&s;investissement vont de &s;1 à 10 millions d&s;euros en minoritaire et majoritaire dans des PME de 5 à 100 M€ de Chiffre d&s;affaires. Le Groupe Turenne Capital compte 32 professionnels dont 21 investisseurs, et gère/conseille plus de 500 M€ confiés par des institutionnels et des particuliers.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
11/2021 | PathoQuest | Series B | 17.4M |
7/2010 | Locster | Venture Round | 670k |
11/2021 | PathoQuest | Series B | 0 |
3/2015 | HalioDx | Series A | 8.9M |
10/2007 | Dromadaire.com | Venture Round | 4.5M |
11/2015 | Snowleader | Venture Round | 2.6M |
3/2017 | Easy Shower | Private Equity Round | - |
12/2008 | Solem Electronique S.A | Venture Round | 5.5M |
4/2018 | Infimed | Private Equity Round | 12.1M |
5/2022 | Domain Therapeutics | Series A | 0 |
4/2012 | Globe Groupe | Private Equity Round | - |
1/2009 | PELLENC Selective Technologies | Venture Round | 1.8M |
4/2018 | Infimed | Private Equity Round | 12.1M |
2/2007 | Ibelem | Venture Round | 1.6M |
8/2010 | Aqua-tools | Venture Round | 8.9M |
7/2020 | Exotrail | Series A | 0 |
9/2012 | Forest-style Group | Private Equity Round | - |
6/2007 | Nexway | Series A | 6.7M |
11/2018 | Intersec | Venture Round | 9.1M |
5/2018 | Notilo Plus | Series A | 2.2M |
6/2019 | My Coach Football | Series A | 7.5M |
7/2010 | Nexway | Series B | 0 |
4/2017 | Training Orchestra | Series A | 5.7M |
6/2013 | DigiSchool | Series A | 3.9M |
8/2019 | GANGZ | Seed Round | 1.1M |
10/2022 | Tradim | Venture Round | 0 |
4/2012 | Claranor | Venture Round | 979.1k |
6/2008 | Toutabo | Venture Round | 3.7M |
7/2019 | Teaminside Group | Venture Round | 11.3M |
3/2019 | Nord Coffrage | Venture Round | 0 |
11/2016 | Fidzup | Series A | 3.2M |
1/2005 | Nexway | Seed Round | 1.4M |
9/2021 | AI Verse | Seed Round | 3M |
1/2018 | STAFFME | Series A | 3.7M |
1/2020 | Aviwest | Series B | 8.8M |
5/2020 | Singulart | Venture Round | 0 |
1/2014 | Se faire aider | Venture Round | 8.6M |
9/2017 | PhysioAssist | Series B | 7.2M |
4/2020 | Seraphin.legal | Venture Round | 2.2M |
7/2017 | MEDIANE | Venture Round | - |
1/2017 | Nomination, SAS | Private Equity Round | 3.2M |
9/2016 | Eurovanille | Venture Round | 5.1M |
10/2019 | M-Energies | Private Equity Round | - |
1/2023 | Amolyt Pharma | Series C | 0 |
12/2020 | Innoskel | Series A | 0 |
2/2021 | Ecodrop | Funding Round | 6M |
7/2020 | MCES | Series A | 2.8M |
6/2000 | MakeMusic, Inc. | Series C | 0 |
3/2010 | PELLENC Selective Technologies | Private Equity Round | 6.8M |
5/2022 | Domain Therapeutics | Series A | 0 |
11/2021 | PathoQuest | Series B | 0 |
2/2021 | Ecodrop | Funding Round | 0 |
12/2020 | Innoskel | Series A | 0 |
7/2020 | Exotrail | Series A | 0 |
7/2020 | MCES | Series A | 0 |
5/2020 | Singulart | Venture Round | 0 |
4/2020 | Seraphin.legal | Venture Round | 0 |
1/2020 | Aviwest | Series B | 0 |
10/2019 | M-Energies | Private Equity Round | - |
Name | Price |
---|
Name | Size | Announced Date |
---|